This product is not intended to diagnose, treat, cure or prevent any disease,
Metabolic comprises multiple conditions existing simultaneously, like insulin resistance, high blood pressure, increased coagulation risk and abnormal cholesterol levels
Compare this to prescription GLP-1 injections administered weekly, maintaining therapeutic levels through long half-life rather than continuous delivery
That has begun: Secondly, while we expected GLP-1 manufacturer share prices to increase in the near term, we were unique in predicting that long-term second-order effects of a successful weight loss drug would be the most enticing trade as competition heated up for the manufacturers (leaving only a few key winners)
Below is a comprehensive timeline based on published data from the STEP trials for semaglutide, the SURMOUNT trials for tirzepatide, and thousands of documented patient experiences